Blockade of PD‐1 or p38 MAP kinase signaling enhances senescent human CD8+ T‐cell proliferation by distinct pathways

Overview of attention for article published in European Journal of Immunology, March 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent: 3 patents

Readers on

mendeley: 97 Mendeley

So far, Altmetric has seen 3 patents that reference this research output.

Molecular engineering to enhance CAR-T mediated tumor immunotherapy

Grant US-12721891-B2

United States of America

A CHIMERIC ANTIGEN RECEPTOR COMBINATORIAL MULTI-ANTIGEN TARGETED ALLOGENEIC T CELL…

Application EP-4509137-A1

European Patent Office

METHODS OF PRODUCING T CELL POPULATIONS USING P38 MAPK INHIBITORS

Application WO-2019075055-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.